Unknown

Dataset Information

0

Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.


ABSTRACT: Small-cell lung cancer (SCLC) is an exceptionally aggressive disease with poor prognosis. Here, we obtained exome, transcriptome and copy-number alteration data from approximately 53 samples consisting of 36 primary human SCLC and normal tissue pairs and 17 matched SCLC and lymphoblastoid cell lines. We also obtained data for 4 primary tumors and 23 SCLC cell lines. We identified 22 significantly mutated genes in SCLC, including genes encoding kinases, G protein-coupled receptors and chromatin-modifying proteins. We found that several members of the SOX family of genes were mutated in SCLC. We also found SOX2 amplification in ?27% of the samples. Suppression of SOX2 using shRNAs blocked proliferation of SOX2-amplified SCLC lines. RNA sequencing identified multiple fusion transcripts and a recurrent RLF-MYCL1 fusion. Silencing of MYCL1 in SCLC cell lines that had the RLF-MYCL1 fusion decreased cell proliferation. These data provide an in-depth view of the spectrum of genomic alterations in SCLC and identify several potential targets for therapeutic intervention.

SUBMITTER: Rudin CM 

PROVIDER: S-EPMC3557461 | BioStudies | 2012-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC3806277 | BioStudies
2016-01-01 | S-EPMC4972690 | BioStudies
2020-01-01 | S-EPMC7216814 | BioStudies
1000-01-01 | S-EPMC452791 | BioStudies
2019-01-01 | S-EPMC6375907 | BioStudies
2017-01-01 | S-EPMC5880621 | BioStudies
2020-01-01 | S-EPMC7166265 | BioStudies
2019-01-01 | S-EPMC6759502 | BioStudies
1000-01-01 | S-EPMC4060123 | BioStudies
2009-01-01 | S-EPMC2783775 | BioStudies